Enoxacin compared with vancomycin for the treatment of experimental methicillin-resistant Staphylococcus aureus endocarditis.
about
Efficacy of pefloxacin-fosfomycin in experimental endocarditis caused by methicillin-resistant Staphylococcus aureusLysostaphin treatment of experimental methicillin-resistant Staphylococcus aureus aortic valve endocarditis.Whole animal automated platform for drug discovery against multi-drug resistant Staphylococcus aureusEvaluation of quinolones in experimental animal models of infections.Antimicrobial resistance and virulence characterization of Staphylococcus aureus and coagulase-negative staphylococci from imported beef meat.Efficacy of ofloxacin in experimental Staphylococcus aureus endocarditisComparison of difloxacin, enoxacin, and cefazolin for the treatment of experimental Staphylococcus aureus endocarditis.Widespread quinolone resistance among methicillin-resistant Staphylococcus aureus isolates in a general hospitalComparison of in vitro activity of quinolone antibiotics and vancomycin against gentamicin- and methicillin-resistant Staphylococcus aureus by time-kill kinetic studies.Methicillin-resistant staphylococci.Development of resistance to fleroxacin during therapy of experimental methicillin-susceptible Staphylococcus aureus endocarditisFluoroquinolone Therapy in Staphylococcus aureus Infections: Where Do We Stand?Mode of action, and in vitro and in vivo activities of the fluoroquinolones.Efficacy of fleroxacin in experimental methicillin-resistant Staphylococcus aureus endocarditis.Altered pharmacokinetic disposition of ciprofloxacin and vancomycin after single and multiple doses in rabbits.Successful therapy of experimental endocarditis caused by vancomycin-resistant Staphylococcus aureus with a combination of vancomycin and beta-lactam antibiotics.Macrolides: problems and promises.
P2860
Q28361126-267FC800-F2B9-460B-8B8E-D427C8D14546Q28379547-FC3B0392-910D-409B-9B74-ED4CDCE1C7E4Q28539903-11BDD137-88F2-4F48-84B6-98D0B38D1054Q30446615-C4DCE1A9-51ED-40F5-9FC7-8507CD51AF05Q33654837-DAECF4D9-38C8-43EC-B1A5-E65874A351DFQ35248574-EDBF43AD-A723-4FF7-9D77-25969DF5049DQ35292551-56958030-FB03-436A-A7E7-1F2152192B20Q35329548-E4EA75BB-3E34-4491-BD98-8996B409EC01Q35653503-9065CD0C-1E3F-43EC-84E6-433A1932E04EQ36632851-55E8A775-C315-43AA-952F-0AF2F62CE8ECQ36754440-9A5F5419-8F2A-4ADE-A854-9A12D4B2DBF2Q37670532-17C0AFBE-7761-4E9D-A6B9-CD26F7A1E8D6Q39637667-8014E97E-7318-47E5-A7F2-2A8CD6F49A53Q39819019-8F811815-E599-441A-B003-8AD923444667Q39828385-F2E9AE0A-77FD-4B6A-80DE-EF161A322DAEQ42001450-2E248222-C612-44AA-8EAB-41E42DF6B69BQ54388935-EE0AAB31-4EF7-4360-B590-D0D2F27B7B32
P2860
Enoxacin compared with vancomycin for the treatment of experimental methicillin-resistant Staphylococcus aureus endocarditis.
description
1986 nî lūn-bûn
@nan
1986年の論文
@ja
1986年論文
@yue
1986年論文
@zh-hant
1986年論文
@zh-hk
1986年論文
@zh-mo
1986年論文
@zh-tw
1986年论文
@wuu
1986年论文
@zh
1986年论文
@zh-cn
name
Enoxacin compared with vancomy ...... ylococcus aureus endocarditis.
@ast
Enoxacin compared with vancomy ...... ylococcus aureus endocarditis.
@en
type
label
Enoxacin compared with vancomy ...... ylococcus aureus endocarditis.
@ast
Enoxacin compared with vancomy ...... ylococcus aureus endocarditis.
@en
prefLabel
Enoxacin compared with vancomy ...... ylococcus aureus endocarditis.
@ast
Enoxacin compared with vancomy ...... ylococcus aureus endocarditis.
@en
P2093
P2860
P356
P1476
Enoxacin compared with vancomy ...... ylococcus aureus endocarditis.
@en
P2093
P2860
P304
P356
10.1128/AAC.29.3.461
P407
P577
1986-03-01T00:00:00Z